A5074585691- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Disease and Adiposity
- Diabetes Treatment and Management
- Lipid metabolism and disorders
- Diet, Metabolism, and Disease
- Receptor Mechanisms and Signaling
- Cardiovascular Health and Disease Prevention
- Metabolism, Diabetes, and Cancer
- Cardiovascular Function and Risk Factors
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Electrolyte and hormonal disorders
- Cardiovascular Health and Risk Factors
- Adipokines, Inflammation, and Metabolic Diseases
- Peroxisome Proliferator-Activated Receptors
Sumitomo Hospital
2022-2024
At the beginning of 2020, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 (SARS-CoV-2) led to epidemics worldwide. Obesity and visceral fat accumulation have been reported be independent risk factors for COVID-19. Several reports focused on levels adipocytokines/adipokines, including adiponectin (APN), which is exclusively secreted from adipocytes, although importance these in conditions remains unclear. Therefore, we investigated relationship between serum...
Abstract Background Ectopic fat is that accumulates in or around specific organs compartments of the body including myocardium. The clinical features type 2 diabetes patients with high accumulation myocardium remain unknown. Moreover, little known about influence myocardial on coronary artery disease and cardiac dysfunction. We aimed to clarify features, functions, accumulation. Methods retrospectively enrolled who underwent ECG-gated computed tomography angiography (CCTA) abdominal (CT)...
A 50-year-old man with a triglyceride (TG) level of 11,397 mg/dL was admitted to our hospital. He consumed high-fat and high-carbohydrate diet as well more than 100 g alcohol per day. had type 2 diabetes obesity previously suffered from severe acute pancreatitis twice. genetic analysis revealed compound heterozygous mutations in APOA5 (c.56C>G c.553G>T). In addition low-fat meals cessation, administration pemafibrate lowered his levels <150 mg/dL.
Background In 2008, the Japanese government implemented a National Intervention Program for metabolic syndrome. Low-risk individuals were not direct targets of this intervention. Nevertheless, they indirectly enlightened by massive campaign. Documentation shifts in low-risk following program launch may inform public health policy regarding approaches to risks general population. Methods We conducted cross-sectional analysis data from non-diabetic participants who underwent check-ups at...